Cubist Systematic Strategies’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.8M | Sell |
26,469
-99,812
| -79% | -$46.5M | 0.06% | 442 |
|
|
2025
Q2 | $51.2M | Buy |
+126,281
| New | +$52.8M | 0.24% | 59 |
|
|
2025
Q1 | – | Sell |
-15,252
| Closed | -$8.26M | – | 3533 |
|
|
2024
Q4 | $7.93M | Buy |
+15,252
| New | +$8.39M | 0.05% | 582 |
|
|
2024
Q3 | – | Sell |
-97,083
| Closed | -$57.5M | – | 3498 |
|
|
2024
Q2 | $53.7M | Buy |
97,083
+90,949
| +1,483% | +$52.1M | 0.37% | 26 |
|
|
2024
Q1 | $3.57M | Buy |
6,134
+3,670
| +149% | +$2.06M | 0.02% | 1205 |
|
|
2023
Q4 | $1.31M | Buy |
+2,464
| New | +$1.19M | 0.01% | 1837 |
|
|
2023
Q3 | – | Sell |
-38,034
| Closed | -$20.3M | – | 3912 |
|
|
2023
Q2 | $19.8M | Buy |
38,034
+37,834
| +18,917% | +$20.4M | 0.13% | 125 |
|
|
2023
Q1 | $115K | Sell |
200
-10,284
| -98% | -$5.8M | ﹤0.01% | 3412 |
|
|
2022
Q4 | $5.77M | Buy |
10,484
+4,371
| +72% | +$2.32M | 0.03% | 887 |
|
|
2022
Q3 | $3.1M | Sell |
6,113
-3,370
| -36% | -$1.89M | 0.02% | 1561 |
|
|
2022
Q2 | $5.15M | Buy |
9,483
+7,219
| +319% | +$3.97M | 0.03% | 967 |
|
|
2022
Q1 | $1.34M | Sell |
2,264
-4,440
| -66% | -$2.55M | 0.01% | 1792 |
|
|
2021
Q4 | $4.47M | Sell |
6,704
-15,356
| -70% | -$9.59M | 0.04% | 730 |
|
|
2021
Q3 | $12.6M | Buy |
22,060
+12,826
| +139% | +$7.04M | 0.16% | 122 |
|
|
2021
Q2 | $4.66M | Sell |
9,234
-59,445
| -87% | -$28M | 0.05% | 580 |
|
|
2021
Q1 | $31.3M | Buy |
68,679
+41,209
| +150% | +$19.7M | 0.4% | 9 |
|
|
2020
Q4 | $12.8M | Buy |
27,470
+23,832
| +655% | +$11.2M | 0.18% | 96 |
|
|
2020
Q3 | $1.61M | Buy |
3,638
+2,938
| +420% | +$1.21M | 0.02% | 1044 |
|
|
2020
Q2 | $254K | Sell |
700
-8,580
| -92% | -$2.88M | ﹤0.01% | 1924 |
|
|
2020
Q1 | $2.63M | Sell |
9,280
-1,306
| -12% | -$412K | 0.07% | 372 |
|
|
2019
Q4 | $3.44M | Sell |
10,586
-6,533
| -38% | -$1.98M | 0.06% | 455 |
|
|
2019
Q3 | $4.99M | Sell |
17,119
-19,763
| -54% | -$5.66M | 0.1% | 297 |
|
|
2019
Q2 | $10.8M | Buy |
36,882
+35,844
| +3,453% | +$9.87M | 0.2% | 102 |
|
|
2019
Q1 | $284K | Sell |
1,038
-25,025
| -96% | -$6.23M | 0.01% | 1538 |
|
|
2018
Q4 | $5.83M | Buy |
26,063
+13,536
| +108% | +$3.18M | 0.28% | 45 |
|
|
2018
Q3 | $3.06M | Buy |
12,527
+11,541
| +1,170% | +$2.66M | 0.17% | 108 |
|
|
2018
Q2 | $204K | Sell |
986
-15,944
| -94% | -$3.38M | 0.01% | 1347 |
|
|
2018
Q1 | $3.5M | Buy |
16,930
+4,825
| +40% | +$1.01M | 0.2% | 109 |
|
|
2017
Q4 | $2.3M | Buy |
12,105
+7,310
| +152% | +$1.4M | 0.12% | 187 |
|
|
2017
Q3 | $907K | Sell |
4,795
-1,253
| -21% | -$227K | 0.05% | 483 |
|
|
2017
Q2 | $1.05M | Sell |
6,048
-21,935
| -78% | -$3.68M | 0.07% | 405 |
|
|
2017
Q1 | $4.3M | Buy |
27,983
+12,219
| +78% | +$1.87M | 0.31% | 33 |
|
|
2016
Q4 | $2.22M | Buy |
15,764
+12,559
| +392% | +$1.85M | 0.18% | 120 |
|
|
2016
Q3 | $510K | Sell |
3,205
-2,242
| -41% | -$345K | 0.03% | 706 |
|
|
2016
Q2 | $805K | Buy |
5,447
+399
| +8% | +$58.9K | 0.05% | 534 |
|
|
2016
Q1 | $715K | Sell |
5,048
-1,535
| -23% | -$206K | 0.04% | 602 |
|
|
2015
Q4 | $934K | Buy |
6,583
+4,030
| +158% | +$538K | 0.05% | 500 |
|
|
2015
Q3 | $312K | Buy |
2,553
+144
| +6% | +$18.8K | 0.02% | 1214 |
|
|
2015
Q2 | $313K | Sell |
2,409
-1,427
| -37% | -$186K | 0.02% | 1211 |
|
|
2015
Q1 | $515K | Sell |
3,836
-38,668
| -91% | -$4.98M | 0.03% | 918 |
|
|
2014
Q4 | $5.33M | Buy |
42,504
+33,763
| +386% | +$4.11M | 0.29% | 43 |
|
|
2014
Q3 | $1.06M | Sell |
8,741
-29,947
| -77% | -$3.64M | 0.07% | 438 |
|
|
2014
Q2 | $4.57M | Buy |
+38,688
| New | +$4.55M | 0.27% | 61 |
|
Other funds holding TMO
Cubist Systematic Strategies's TMO Position: Q3 2025 in Review
Cubist Systematic Strategies reduced its Thermo Fisher Scientific (TMO) stake by 79% in Q3 2025, selling an estimated $46.5M and leaving 26,469 shares worth $12.8M. The position accounts for 0.06% of the portfolio, ranked #442.
Cubist Systematic Strategies first reported a position in TMO in Q2 2014 and has held it in 43 quarters since. The position peaked at $53.7M in Q2 2024. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- Cubist Systematic Strategies held 26,469 shares of Thermo Fisher Scientific worth $12.8M as of Q3 2025.
- Cubist Systematic Strategies sold 99,812 Thermo Fisher Scientific shares in Q3 2025, an estimated $46.5M.
- Thermo Fisher Scientific made up 0.06% of Cubist Systematic Strategies's portfolio in Q3 2025, its #442 holding.
- Cubist Systematic Strategies first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 43 quarters since.
- Cubist Systematic Strategies's Thermo Fisher Scientific position peaked at $53.7M in Q2 2024.
- 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.